Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Egg Shell and TiO2 Nanoparticles for Dentin Hypersensitivity
NCT06025084Phase 1Completed
- Sponsor
- Egymedicalpedia
- Start
- Dec 2022
- Primary completion
- Mar 2023
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Phase 1, randomised trial of egg shell nanoparticles and titanium dioxide nanoparticles in dentin hypersensitivity (DH) (2 arms), sponsored by Egymedicalpedia. Primary endpoint: Visual Analog Scale Score at 2 months. Started Dec 2022; status: completed.
02
Drugs
egg shell nanoparticlestitanium dioxide nanoparticles
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT06025084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06025084.